WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2015028848) BICYCLIC HETEROCYCLIC COMPOUNDS AS MULTI-KINASE INHIBITORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2015/028848    International Application No.:    PCT/IB2013/058215
Publication Date: 05.03.2015 International Filing Date: 02.09.2013
IPC:
C07D 403/12 (2006.01), C07D 403/14 (2006.01), A61K 31/517 (2006.01), A61P 3/00 (2006.01), A61P 9/00 (2006.01), A61P 25/00 (2006.01), A61P 35/00 (2006.01), A61P 37/00 (2006.01)
Applicants: PIRAMAL ENTERPRISES LIMITED [IN/IN]; Piramal Tower, Ganpatrao Kadam Marg, Lower Parel Mumbai 400 013 (IN)
Inventors: ROYCHOWDHURY, Abhijit; (IN).
SHARMA, Rajiv; (IN).
AWARE, Valmik; (IN).
CHAVAN, Sambhaji; (IN).
GAIKWAD, Nitin; (IN)
Priority Data:
Title (EN) BICYCLIC HETEROCYCLIC COMPOUNDS AS MULTI-KINASE INHIBITORS
(FR) COMPOSÉS HÉTÉROCYCLIQUES BICYCLIQUES UTILISÉS COMME INHIBITEURS DE PLUSIEURS KINASES
Abstract: front page image
(EN)The present invention provides bicyclic heterocyclic compounds (the compounds of formula I, or an isotopic form, a stereoisomer or a tautomer or a pharmaceutically acceptable salt, a solvate, a polymorph, a prodrug or N-oxide thereof and processes for their preparation. The invention further relates to pharmaceutical compositions containing said compounds and their use in the treatment of diseases or disorders associated with abnormal protein kinase activity.
(FR)La présente invention porte sur des composés hétérocycliques bicycliques (les composés de formule I) ou une forme isotope, un stéréoisomère ou un tautomère ou un sel pharmaceutiquement acceptable, un solvate, un polymorphe, un promédicament ou un N-oxyde de ceux-ci et sur des procédés pour leur préparation. L'invention porte en outre sur des compositions pharmaceutiques contenant lesdits composés et sur leur utilisation dans le traitement de maladies ou de troubles associés à une activité anormale de protéines kinases .
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)